Aziyo Biologics Inc.
AZYO
NSD
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
6.47
USD
0.00
(0.00%)
Optionable: No Market Cap: 90 M 90-day average vol: 0
Previous close: 6.466 Open: Bid: Ask:
52 week range
0.00 0.00
Last updated: Monday 8th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 1.82 |
Price per Book TTM ($) | 13.60 |
PE Ratio (TTM) | -2.60 |
Book Value per Share ($) | 0.48 |
5 Year PE Range | -2.4 , -1.5 |
Returns
7 Day Return | -1.28% | |
1 Month Return | 4.80% | |
3 Month Return | 0.72% | |
1 Year Return | -22.10% | |
3 Year Return | -55.41% | |
5 Year Return | -55.41% | |
YTD Return | 2.63% |
Risk
Custom Beta One Year | 0.42 |
Custom Beta Three Years | 0.29 |
Beneish M Score | -3.11 |
Altman Z Score | -1.11 |
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 51.86 |
14 Day SMA ($) | 6.42 |
14 Day EMA ($) | 6.42 |
Money Flow Index | 74.13 |
Average True Range | 1.24 |
50 Day SMA ($) | 6.38 |
200 Day SMA ($) | 6.10 |
ADX | 0.00 |
MACD | 0.04 |
Growth
Free Cash Flow QoQ Growth | 15.16% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -26.83% |
Revenue QoQ Growth | 5.84% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference
Yahoo Finance 2/23/2022
Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022
Yahoo Finance 2/17/2022
All You Need to Know About Aziyo Biologics, Inc. (AZYO) Rating Upgrade to Buy
Yahoo Finance 2/14/2022
Has Aziyo Biologics, Inc. (AZYO) Outpaced Other Medical Stocks This Year?
Yahoo Finance 2/14/2022
Aziyo Biologics (AZYO) Investor Presentation - Slideshow
Seeking Alpha 2/3/2022
Stonegate Capital Partners Initiates Coverage on Aziyo Biologics, Inc. (NASDAQ:AZYO)
Yahoo Finance 1/18/2022
Wall Street Analysts See a 123% Upside in Aziyo Biologics, Inc. (AZYO): Can the Stock Really Move This High?
Yahoo Finance 1/11/2022
Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference
Yahoo Finance 12/27/2021
Aziyo Biologics Announces Closing of $14.0 Million Private Placement
Yahoo Finance 12/8/2021
Aziyo Biologics Announces $14.0 Million Private Placement
Yahoo Finance 12/6/2021
Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences
Yahoo Finance 11/15/2021
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q3 2021 Results - Earnings Call Transcript
Seeking Alpha 11/9/2021
Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Misses Revenue Estimates
Yahoo Finance 11/9/2021
Aziyo Biologics EPS misses by $0.19, revenue in-line
Seeking Alpha 11/9/2021
Aziyo Biologics Reports Third Quarter 2021 Financial Results
Yahoo Finance 11/9/2021
Will Aziyo Biologics, Inc. (AZYO) Report Negative Earnings Next Week? What You Should Know
Yahoo Finance 11/2/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: -0.31
Financials
AZYO Income Statement
Annual
| Invalid date | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|
| Total revenues | 39 M | 43 M | 43 M | 47 M | |
| Cost of sales | 19 M | 19 M | 18 M | 25 M | |
| Gross operating profit | -373000 | 8 M | 21 M | 19 M | |
| Selling Gen & administrative expense | 22 M | 26 M | 28 M | 33 M | |
| Research & development expense | 2 M | 2 M | 6 M | 9 M | |
| Operating income | -8 M | -8 M | -14 M | -23 M | |
| floaterest income | 0 | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | 0 | |
| Other income net | 2 M | 2 M | -3 M | 4 M | |
| Pre-tax Income (EBT) | -12 M | -12 M | -22 M | -25 M | |
| Income taxes | 26000 | 30000 | 26000 | 55000 | |
| Net income from total operations | -12 M | -12 M | -22 M | -25 M | |
| Minority floaterest | 0 | 0 | 0 | 0 | |
| Total net income | -12 M | -12 M | -22 M | -25 M | |
| Preferred dividends | N/A | N/A | N/A | N/A | |
| Net income available for common | -12 M | -12 M | -22 M | -25 M | |
| Depreciation | 4 M | 4 M | 4 M | 4 M | |
| Amortization | 0 | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | -2 M | -3 M | -12 M | -16 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | |
| Basic EPS total | -1.83 | -1.89 | -8.88 | -2.38 | |
| Diluted EPS total | -1.83 | -1.89 | -8.88 | -2.38 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!